G

GE Healthcare

Imaging, monitoring, and healthcare IT solutions

Clinical Application Specialist - Anesthesia & Respiratory Care

Full-TimeUpdated on 10/16/2026
$124.2k - $186.4k/yr+ Performance-based cash bonus(es) + Long-term incentives
Mid
Remote in USA
RemoteExtensive travel within the US and Canada (4–5 days per week, including some weekends). Relocation assistance is provided.
Customer Experience & SupportCustomer Education & Training
No H1B Sponsorship

About the job

Requirements
  • Hold an active Registered Respiratory Therapist license and have 3–5 years of ICU experience.
  • Be able and willing to travel extensively, 100+% (4–5 days per week, including some weekends), within the United States and Canada using multiple modes of transportation as necessary.
  • Maintain a valid driver’s license and satisfactory driving record.
  • Proficiently use software applications such as Windows Outlook, Word, PowerPoint, and Excel, and navigate other computer- and web-based tools, including intranet, internet, and apps.
  • Be able to learn specialized industry-specific software and provide digital education and training solutions.
  • Be willing to submit to a background investigation, including verification of past employment, criminal history, and educational background, and to take a drug test.
  • Register with one or more vendor credentialing services required by customer hospitals, including providing proof of immunization for MMR and hepatitis and undergoing drug testing or screening.
  • Meet customer site-access requirements, including COVID-19 vaccination where applicable.
  • Be willing to work out of an office or home/remote office.
Responsibilities
  • Develop product, clinical, and software knowledge, skills, and competence within a specific Patient Care Solutions modality.
  • Correlate theoretical knowledge with clinical and product information to help clinicians obtain optimal performance from GE Healthcare equipment.
  • Provide pre-sale product clinical evaluations and/or educational sessions to potential customers.
  • Partner with customers to develop and administer clinical training for end-user personnel in alignment with the sales order agreement, delivering clinical education intended to achieve strong Net Promoter Scores.
  • Coordinate customer training delivery with sales, project management, and other service organization teams using a targeted integrated account-management approach and following the sales order agreement and its terms and conditions.
  • Drive revenue realization through on-site or remote clinical education delivery.
  • Complete pre- through post-training documentation comprehensively, consistently, and on time.
  • Provide ongoing post-installation training and support, including additional training for existing customers and training or implementation for product enhancements as needed.
  • Maintain customer relationships and communicate relevant product or customer concerns and opportunities to Patient Care Solutions management, Field Sales, Marketing, Customer Loyalty Leads, and Technical Support, including technical and clinical issues and opportunities to improve product quality or offerings.
  • Manage the travel and expenses budget to plan by optimizing travel strategies and costs; submit expense reports within guidelines and maintain clear, complete records in compliance with position requirements.

About the company

GE Healthcare Systems provides medical technologies and digital infrastructure to improve diagnosis, treatment, and monitoring of patients. Its products include imaging systems, mobile diagnostic devices, patient monitoring tools, and healthcare IT software that work together as hardware, software, and services to support hospitals, clinics, and researchers. The company differentiates itself with a large, integrated ecosystem, strong focus on AI analytics, and a global service network backed by substantial R&D investment. Its goal is to improve patient outcomes and the efficiency of healthcare delivery by enabling accurate diagnoses, effective treatments, and scaled operations.

Company Size

1-10

Company Stage

IPO

Headquarters

Chicago, Illinois

Founded

1892

Get referred to GE Healthcare

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Q2 2026 orders rose 11% and backlog reached a record $23.9 billion.
  • CareIntellect for Operations launched September 2026 with Duke Health and Queen's Health Systems.
  • CE mark and FDA progress for Photonova Spectra expand 2026-2027 commercial momentum.

What critics are saying

  • FDA logged multiple 2026 Class 2 recalls, including AW Server and telemetry systems.
  • Patient Care Solutions remained weak in Q2 2026; management is reviewing a sale.
  • SOFIE closes only after 2027 regulatory approvals; PET supply integration can slip badly.

What makes GE Healthcare unique

  • GE HealthCare combines imaging hardware, radiopharmaceuticals, and workflow software across hospitals.
  • Photonova Spectra and Vivid 2026 show premium innovation plus AI-enabled clinical automation.
  • SOFIE's 21 cyclotrons extend GE HealthCare into radiotracer manufacturing, not just scanners.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

401(k) Retirement Plan

401(k) Company Match

Tuition Reimbursement

Relocation Assistance

Company News

Business Wire
Oct 5th, 2026
GE HealthCare to acquire SOFIE Biosciences for $945M to expand US radiopharmaceutical supply

GE HealthCare has agreed to acquire SOFIE Biosciences, a US-based contract manufacturer of PET radiopharmaceuticals, for $945 million in cash. The deal with seller Trilantic North America is expected to close in the first half of 2027, subject to regulatory approvals. SOFIE Biosciences operates 15 contract manufacturing sites with 21 cyclotrons across the US, plus a theranostics-focused development and manufacturing facility. The acquisition establishes GE HealthCare's presence in the time-critical "final mile" of US PET radiopharmaceutical supply. The PET radiopharmaceutical market is expanding rapidly with approximately 20 PET radiotracers and over 30 radiotherapeutics currently under development. SOFIE Biosciences' portfolio includes a Phase III FAPI asset for which GE HealthCare already holds non-US rights. GE HealthCare estimates the transaction will be accretive to revenue growth, earnings margin, and earnings per share in the first full year of ownership.

PR Newswire
Sep 30th, 2026
AsiaMedic first in ASEAN to deploy GE HealthCare's MR31 deep learning MRI platform

AsiaMedic has become the first site in ASEAN to implement MR31, GE HealthCare's latest generation MRI platform featuring deep learning technology. The Singapore-based imaging centre is among the earliest adopters in Asia Pacific. MR31 incorporates deep learning technologies that reduce scan times and enable detailed examinations across neurological, musculoskeletal and nerve imaging. Sonic DL for 3D delivers up to 12 times scan acceleration, reducing examination times across brain, spine, orthopaedic and body scans. The platform also supports high-quality prostate MRI imaging. AIR Recon DL Phase Correction provides improved visualisation of clinically significant lesions, whilst high-resolution T2-weighted imaging aids lesion localisation for prostate fusion biopsy planning. Shorter scan times mean reduced patient time in scanners and may help decrease repeat examinations caused by movement.

Associated Press
Sep 22nd, 2026
GE HealthCare raises quarterly dividend 14% to $0.04 per share for Q3 2026

GE HealthCare Technologies announced a 14% dividend increase for the third quarter of 2026. The company's board declared a cash dividend of $0.04 per share, up from the previous quarter. The dividend will be paid on 13 November 2026 to shareholders of record as of 23 October 2026. GE HealthCare is a global healthcare solutions provider specialising in medical technology, pharmaceutical diagnostics, and AI-enabled software solutions. The company operates a $20.6 billion business with approximately 54,000 employees worldwide, serving the healthcare industry through its Advanced Imaging Solutions, Pharmaceutical Diagnostics, and Patient Care Solutions segments.

Yahoo Finance
Sep 15th, 2026
GE HealthCare launches AI tool to forecast hospital capacity bottlenecks 72 hours ahead

GE HealthCare has launched CareIntellect for Operations, an AI-powered software application that helps health systems forecast capacity constraints up to 72 hours ahead. The solution analyses hundreds of patient and operational data points to predict bottlenecks and recommend actions to optimise capacity and throughput. The Queen's Health Systems and Duke Health will be the first to implement the application. It uses two proprietary AI models: the Pressure Forecast model, which predicts resource constraints across hospitals and departments, and the Estimated Day of Discharge model, which predicts when patients will be discharged. The tool addresses operational challenges as US inpatient volumes rose 5.3% in 2025, requiring health systems to manage increased demand whilst facing staffing shortages and rising costs.

Yahoo Finance
Sep 1st, 2026
GE HealthCare secures CE mark for Photonova Spectra photon-counting CT system

GE HealthCare has received CE mark approval for its Photonova Spectra photon-counting computed tomography system, enabling commercial sales in markets recognising CE marking. The clearance follows US Food and Drug Administration approval and Japanese regulatory clearance in March 2026. The system uses GE HealthCare's Deep Silicon detector technology to deliver ultra-high definition spectral and spatial imaging. It processes data volumes up to 50 times greater than conventional CT systems, utilising Nvidia's accelerated computing platform. Clinical collaborations are underway at UZ Brussel in Belgium and Rigshospitalet in Denmark to evaluate the system across cardiology, neurology, oncology and musculoskeletal imaging. The CE mark follows more than $5 billion in innovation investment by GE HealthCare.